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Abstract 
In  this  study, we observed the effect of propolis  extract on immunological function in diabetic 
mouse models with the aim of highlighting the dynamics of immunological status in type-2 
diabetes. In this study we tested the ability of propolis to normalize homeostasis. Here we 
showed that propolis improve homeostasis by slightly increasing the level of TLR expression. 
The results of this study differ from previous findings which reported that TLR expression 
increased in diabetes mellitus and most treatment is intended to suppress the expression of 
TLR. In this study we found that TLR-3 and TLR-4 expression decreased in mouse models of 
STZ induced diabetes mellitus. Furthermore, we found that administration of propolis showed 
an increase of red blood cell precursors (TER-119) and improve the ratio of CD4:CD8 dependent 
manner. 
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Introduction 
Currently about 348 million people worldwide suffer from diabetes mellitus (DM). DM is the most 
deadly diseases and has penetrated all countries. It is currently known, 4.6% of the total Indonesian 
population suffer from diabetes mellitus, and this will increase to 7.8% in 2030. During this time, the 
treatment of various diseases including diabetes really dependent on synthetic drugs. On the other 
hand, Indonesia has abundant of natural resources with the potential to cure various diseases. 
Propolis is one of Indonesia's pride traditional medicine which is often claimed by the community with 
ability to cure diabetes mellitus. But unfortunately there have not enough research been done on this 
existing claims. On the other hand, patients with diabetes mellitus want to get the right medicine to 
improve the quality of their life. In general, the severity of diabetes is triggered by inflammation 
factors known as  proinflammatory cytokines. Administration of propolis to diabetic mice results in a 
significant decrease of blood sugar levels and increases the number of naïve T cells. When propolis 
was given to normal or diabetic mice, it can increase the number of regulatory T cells. In mouse 
models of diabetes mellitus the development of effector cells can be suppressed after propolis 
administration. In individual with diabetes mellitus propolis tends to suppress IFN-γ but rather 
increased TLR production.  
 
Materials and Methods 
Procedure  
Preparations of Ethanol Extract of Propolis. 
Propolis extract preaparation consisted of three phases including drying, extracting, and evaporating. 
The drying process began by washing the sample, cutting it into small pieces, and putting them in the 
oven with 40-60ºC degree. Samples were dried and crushed by a blender. As much as 100 grams of 
dry samples were weighed and put in 1 L Erlenmeyer glass, soaked with ethanol to the volume of 1 L 
before the extraction process. Sample in ethanol was stirred for ± 30 minutes and allowed to stand 
overnight to settle. Supernatant was removed and filtered. The extract of propolis was dried by using 
an evaporator and weighed. Propolis powder was then dissolved in distilled water for oral treatment. 
Type 2 diabetes mice models were then treated with the ethanol extract of propolis for 7 weeks. Mice 
were maintained in pathogen free facility. Mice were fed with pellets BR1 by 5-10 grams per day and 
drink was provided ad libitum.  
 
Induction of Type 2 diabetes mellitus with STZ. 
Streptozotonin (STZ) dissolved in 0:01 M citrate buffer, pH 4.5 and always prepared in a fresh 
condition. STZ was intraperitoneally injected to mice in the age of 5 days (100 mg/kg BW). Five weeks 
after STZ injection, diabetic condition is confirmed by measuring the glucose levels using a glucometer 
(GlucoCare Ultima). 
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Results and Discussion 
In this study we showed that TLR-3 expression in diabetic mice decreased  6 times lower than normal. 
The suppression of TLR-3 expression is suspected to affect the quality of homeostasis because TLR-3 
normally functions as an activator of innate immunity. The low expression of TLR-3 in turn make 
difficulty for eliminating infectious agents in patient  with diabetes mellitus. So that in many cases 
people with diabetes mellitus often wounds and difficult to be cured. However, the increase of TLR-3 
expression far beyond normal will bring  bad impacts and also aggravate diabetic patient health 
conditions.  
 
 
 
 
 
 
 
 
 
 
Figure 1. In mice models of diabetes mellitus induced by STZ, expression level of TLR-3 decreased  
 
Left panel showed TLR-3 expression on CD4 cells in normal mice. Right panel is an expression of TLR-
3 on CD4 T cells in mouse models of DM. Cells were isolated from spleen and analyzed by flow 
cytometry. CD4 positive cells expressing TLR-3 (CD4+TLR-3+)  were shown in each panel. 
 
Observations on CD4 T cells clearly showed that the expression of TLR-3 decreased in mouse model of 
diabetes. In this experiment we cannot explain the site effect of TLR decline on T lymphocytes. 
However, there is a little clue that the decline of TLR expression may correlate with the failure of 
patient in eliminating foreign antigen specially bacteria and virus. TLR-3 has been known to be 
associated with the emergence of signal transduction related to virus elimination. The decline of TLR-3 
expression in DM will lead to the emergence of disorders associated with TLR-3 function. 
 
 
 
 
 
 
 
 
 
 
Figure 2. Administration of propolis in mice model of diabetes increase the expression of TLR-3 on 
CD4 cells approaching normal conditions 
 
From left panel to right is propolis treatment at a dose of 50, 100, and 200 mg/kg BW recpectively. 
The cells were isolated from spleen and analyzed by flow cytometry. CD4 positive cells expressing 
TLR-3 (CD4+TLR-3+)  were shown in each panel. 
 
Conclusions 
TLR-3 expression in diabetic mouse models decrease on CD4 T cells. Propolis can normalize 
homeostasis by slightly increasing the level of TLR expression. In general, diabetic mice models that 
had received propolis develop into healthy signed by the decline in glucose levels and also physiologic 
improvements. The ratio of T lymphocytes seem to be normalized after consuming propolis for two 
weeks. Interestingly, propolis has ability to increase the precursor of red blood cells. 
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